# People Deserve Better Conversations

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/testimonial/people-deserve-better-conversations/
> **Published:** 2026-10-07T17:47:56-04:00 | **Last Modified / Clinically Audited:** 2026-10-07T17:55:59-04:00
> **Clinical Summary:** I’ve watched conversations about cannabis become increasingly polarized, emotional, and oversimplified. But real life is rarely that simple. People deserve something better than slogans or arguments. They deserve thoughtful, informed conversations that acknowledge complexity, uncertainty, and individual experience. That is the kind of approach I value most, and the kind of conversation I believe we […]

---

I’ve watched conversations about cannabis become increasingly polarized, emotional, and oversimplified. But real life is rarely that simple. People deserve something better than slogans or arguments. They deserve thoughtful, informed conversations that acknowledge complexity, uncertainty, and individual experience. That is the kind of approach I value most, and the kind of conversation I believe we need more of.

Ron T

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).